Direkt zum Inhalt
Merck

Multidrug-resistant tuberculosis that required 2 years for diagnosis.

BMJ case reports (2012-05-19)
Shuichi Yano, Kanako Kobayashi, Toshikazu Ikeda
ZUSAMMENFASSUNG

Isoniazid (H) or rifampicin (R) mono-resistant disease can be treated easily and effectively with first-line drugs, while combined H and R resistance (ie, multidrug-resistant tuberculosis (MDRTB)) requires treatment with at least four agents, including a quinolone and an injectable agent. Drug-resistant Mycobacterium tuberculosis strains are reported to be extremely difficult to cultivate invitro. The authors report a case of MDRTB that required 2 years for diagnosis, and was detected only in sputum culture on solid medium. Physicians should consider MDRTB if TB is suspected but pathogens are not detected.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
4-Amino-salicylsäure, 99%
Sigma-Aldrich
Natrium-4-amino-salicylat Dihydrat, ≥97.0% (T)